Ursolic acid morpholine and diethanolamine salts

A method for:

• (i) increasing skeletal muscle mass;
• (ii) treating skeletal muscle atrophy;
• (iii) treating sarcopenia;
• (iv) treating cachexia;
• (v) increasing strength;
• (vi) treating weakness;
• (vii) increasing exercise capacity;
• (viii) treating fatigue;
• (ix) promoting muscle growth;
• (x) promoting normal muscle function;
• (xi) improving muscle function;
• (xii) promoting muscle health;
• (xiii) promoting healthy aging in muscles;
• (xiv) increasing energy expenditure;
• (xv) increasing the ratio of skeletal muscle to fat;
• (xvi) reducing fat;
• (xvii) treating obesity;
• (xviii) treating diabetes;
• (xix) lowering blood glucose;
• (xx) treating pre-diabetes;
• (xxi) treating metabolic syndrome;
• (xxii) treating insulin resistance;
• (xxiii) reducing plasma cholesterol;
• (xxiv) treating hypercholesterolemia;
• (xxv) reducing plasma triglycerides;
• (xxvi) treating hypertriglyceridemia;
• (xxvii) promoting healthy metabolism;
• (xxviii) promoting metabolic health;
• (xxix) treating non-alcoholic fatty liver disease (NAFLD);
• (xxx) treating a disease state, condition, or disorder mediated by activating transcription factor 4 (ATF4),
• in a subject, the method comprising administering to the subject an effective amount of an ursolic acid salt selected from ursolic acid diethanolamine salt and ursolic acid morpholine salt.